Videos
The Lead
IPS Technology Tours at INTERPHEX 2013
May 31, 2013 | Comments
During INTERPHEX 2013 Integrated Project Services (IPS) again held their technology tours on the floor of the show. Tour participants, guided by IPS subject matter experts, visited leading providers of equipment in the areas of Advanced Aseptic technologies, Biomanufacturing technologies, Oral Solid Dosage technologies and new this year, Modular Construction technologies.
Preparing for a Pandemic
June 18, 2013 8:29 am | Comments
Mary Mahoney, North Shore Long Island Jewish Medical director of Emergency Planning and...
Can Hot Peppers Knock Out Cancer?
June 17, 2013 8:36 am | Comments
Super hot peppers can make you sweat and tear up, but they also...
FDA Seeks Better Security for Medical Devices
June 14, 2013 8:56 am | Comments
The Food and Drug Administration is proposing new regulations to require medical device makers...
FREE Daily Email Newsletter
Supreme Court Says Human Genes Are Not Patentable
June 13, 2013 12:17 pm | by Wall Street Journal | CommentsThe Supreme Court unanimously ruled that human genes isolated from the body can’t be patented, a victory for doctors and patients who argued that such patents interfere with scientific research and the practice of medicine. The patentability of those isolated genes was challenged by researchers and scientists and other scientists.
Sleep Apnea Increases Risk of Heart Attack, Study Finds
June 12, 2013 1:44 pm | CommentsA long-term study from the Mayo Clinic highlights the danger of sleep apnea and its connection to cardiac arrest. Dr. Carol Ash, director of sleep medicine at Meridian Health, talks to the "CBS This Morning" co-hosts about how to recognize the symptoms of this disorder.
E-Cigarettes Catch Fire With Investors, Regulators
June 11, 2013 8:48 am | CommentsElectronic cigarettes are hot right now. While the cigarettes currently only account for 1% of the tobacco market their growth has doubled in size every year. But the young industry faces some very real hurdles from health and safety regulators.
First FDA Approved Weight Loss Drug in 10 Years on the Market
June 10, 2013 8:45 am | CommentsBelviq will be available to U.S. patients this next week, nearly a year after the drug was officially approved by federal regulators. The FDA approved Belviq last June for adults who are obese or who are overweight and have at least one serious medical condition, such as diabetes or high cholesterol.
FDA: More Study Needed on Life-Saving Baby Drug
June 7, 2013 8:30 am | CommentsDr. Mark Puder of Boston Children’s Hospital developed a treatment with a drug made with fish oil called Omegaven that he’s been using to help reverse fatal liver disease in infants. Despite the drug’s effectiveness, it has yet to be approved by the FDA. Puder says the FDA has told him they want the usual rigorous controlled study where half the patients get the experimental drug and the other does not.
Avandia: FDA May Reverse Restrictions
June 6, 2013 8:57 am | CommentsOnce the top-selling diabetes pill in the world, Avandia was severely restricted by the Food and Drug Administration after reports that taking the drug could raise the risk of heart attack. But now, the agency may be on the verge of reversing those restrictions.
First Step to Fight TB: Fix Drug Shortage
June 6, 2013 8:51 am | CommentsThe United States, India and other nations around the world are facing a shortage of tuberculosis drugs. The Wall Street Journal’s Geeta Anand talks with Bobby John, head of Global Advocates, about finding possible solutions to fighting this deadly disease.
What New Diagnoses Could Mean for Pharma Industry
June 5, 2013 8:48 am | CommentsChanges to the DSM-5, the updated manual of psychiatric illnesses released earlier this month, include 15 new disorders. The Wall Street Journal’s Jen Wieczner looks at how these new disorders could spell new market opportunities for Big Pharma.
Smart Drugs. Too Good to be True?
June 5, 2013 8:38 am | CommentsIf there was a pill to make you smarter would you take it? A new generation of so-called “smart” drugs is being used by people looking for an edge, but doctors warn of serious potential side effects. Dr. Jeffrey Lieberman of Columbia University Medical Center offers his perspective.
New Drugs Raise Hope for MS Patients
June 4, 2013 8:44 am | CommentsTreatment for muscular dystrophy, which typically kills patients by their thirties, has not advanced much since the 1980’s. Wall Street Journal reporter Jonathon Rockoff talks about a new generation of drugs that promises to extend patient’s lives by years or decades.
More Children Poisoned by Prescription Pills
June 4, 2013 8:36 am | CommentsAs more adults use prescription drugs, the rate of children being poisoned by them has also dramatically increased. This report details how one family with two young daughters makes sure their prescription drugs stay out of their hands to prevent accidental poisoning.
Study: Antibiotics Overused
June 3, 2013 8:43 am | CommentsAntibiotics are one of the most prescribed medications but new research finds that some infections may be best treated with no medicine at all. In particular, two conditions, sinusitis which may be caused by a virus and middle-ear infections might not need antibiotics.
New AIDS Vaccine Trial Launched
May 31, 2013 8:43 am | CommentsA new vaccine in the war against HIV could be a step closer as scientists begin a new clinical trial in London and Africa. Initially the trial will enroll 64 volunteers between the ages of 18 and 50 who are at low risk for contracting HIV.
WHO: Coronavirus – “Threat to the World”
May 30, 2013 8:51 am | CommentsThe World Health Organization (WHO) is calling the coronovirus or the Middle East Respiratory Syndrome Coronavirus a threat to the world as the virus has many unknown factors and has killed approximately 55 percent of those infected. Cases have been reported in the Middle East and have spread to parts of Europe.
Mom Fights to Save Sons from Deadly Disease
May 29, 2013 9:01 am | CommentsBoth of Jen McNary's sons suffer from the same deadly disease known as Duschene muscular dystrophy. The difference is one son has qualified for a clinical trial of a new drug and the other hasn't. The son on the new drug is improving and the condition of the son denied the drug is slowly deterioriating.
